MIFLONID 200

200MCG INH PLV CPS DUR 120

SÚKL code 0016302
Name of the product MIFLONID 200
_MA_MEDICATION_DETAIL_INFO_MED_NAME i MIFLONID 200
Supplement 200MCG INH PLV CPS DUR 120
Strenght 200MCG
Pharmaceutical form Inhalation powder, hard capsule
Package 120
Route Inhalation use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance BUDESONIDE (BUDESONIDUM)
ATC group R03BA02
ATC group name BUDESONID

Marketing authorisation information

Registration Number 14/ 232/00-C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 03. 2017
MA Holder Novartis s.r.o., Praha
MA Holder country ČESKÁ REPUBLIKA
Actual MA holder Novartis s.r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list